Digital Learning

White Papers

Detect and Characterize In Vitro PCCs of Non-Cleavable ADCs Using a New LC-HRMS Method

Unknowns are Unacceptable

Pharmacokinetic Bioanalysis Strategies for Antibody-Drug Conjugates (ADCs)
Based on LC-MS

The BAMA MINIPIG in Toxicology

ICH M10 Guidance: Harmonization and Modification to Bioanalytical Method Variation

Comparison Between Magnetic Bead and Membrane Immunoaffinity Purification Methods for the Measurement of Monoclonal Antibody in Rat Serum

Internal Standard (IS) Variation Case Studies: Emerging From Three Common IS Challenges

Metabolite Identification (MetID): A Critical Step in Drug Discovery and Development

Bridging Preclinical and Clinical Assays for Biologics Development –Challenges and Considerations for Phase I Trials

The 2019 FDA Guidance’s Implications for Immunogenicity Assessment

Service Catalog

Drug Metabolism and Pharmacokinetics


Safety Assessment Services Brochure

Oligonucleotide Drugs

Safety Assessment Services Brochure

Antibody Drug Conjugate

Safety Assessment Services Brochure

Safety Assessment Services

Safety Assessment Services Brochure

Proteolysis Targeting Chimera

Safety Assessment Services Brochure


Safety Assessment Services Brochure

Peptide-Drug Conjugate


The Strategies and Methods of in-vitro ADME Characterizations of ADCs

DMPK Challenges and Strategies for Developing Oligonucleotide Drugs

DMPK Optimization of Proteolysis-Targeting Chimeras

DMPK Strategies for Oligonucleotide Therapeutics

Hot Topics and Challenges in Drug Development

Expediting Biologics Drug Development: Strategies to Accelerate Preclinical Development Timelines

DMPK Strategies for Successful Clinical Translation

DMPK Addressing Safety Testing of Drug Metabolites (MIST) in Drug Development

AAPS – The Unique Bioanalytical Needs of New Modalities


Bioanalysis in Gene and Cell Therapy